Tirzepatide Tirzepatide is a once weekly GIP (Glucose-depenent Insulinotropic Polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, representing a new class of medicines studied for the treatment of obesity
Remember, knowledge is power, and with the right information, we can make informed decisions about our health journeys.
It protects esophageal epithelia and breast cancer cells from oxidative stress [19]
BPC-157 Dose Quick-Reference Table If you only need the numbers, start here
They can minimize the effects of sun damage and acne and reduce the visibility of scars, fine lines, and wrinkles
To book your consultation, simply choose your location, select the service category, and the consultation you wish to book with us or get in touch if you have any questions